[ad_1]
“I have to be honest – the last thing I think about before I go to bed are the variables and the first thing I think of in the morning are the variables,” Lindquist said at a press briefing this week.
And while federal health officials are most wary of the delta variant — the B.1.617.2 strain first seen in India — other variants are also gaining traction in parts of the United States.
One of them is the gamma variant, also known as P.1, which quickly spread to dominate Brazil.
“We’ve seen it all over the state of course, but we’re seeing it in some outbreaks in eastern Washington, and we’re seeing it in counties with low vaccination rates, and I’m very concerned about the role that page 1 plays. It’s going to take. It’s increased in this state.”
To date, none of the most common variants shows a significant ability to avoid the effects of full vaccination. But many of them have demonstrated the ability, in laboratories and in real life, to re-infect people who have recovered from a natural coronavirus infection and to infect people who have only been partially vaccinated.
Vaccine experts agreed that fully vaccinated people with a strong and broad immune response should be concerned about the variants.
Gamma is classified as a type of anxiety disorder by the US Centers for Disease Control and Prevention. A worrisome variant shows evidence of increased transmissibility, more severe disease, lower antibody efficacy, lower treatment efficacy, or diagnostic problems, according to the CDC.
According to the CDC’s variant tracker, Gamma was detected in every state where the CDC contained different information. According to the latest tracking data, gamma prevalence is over 15% in multiple regions, including the West and Northeast.
Frequency increase in multiple cases
While the dominant strain in the state is still alpha – also known as B.1.1.7 and first identified in the UK – the gamma variant is common in Rhode Island, said Dr. Philip Chan, consultant medical director at the Rhode Island Department of Health. .
“If you look at trends over time, what we’ve seen about the past few weeks, about 20% of all variables have been gamma variable and have been stable over the past few weeks,” he told CNN.
According to the California Department of Public Health, gamma made up 10% of all sequencing samples in May, and is “increasing in all areas of California.”
“Public health officials are concerned about the gamma variant and several other variables of concern, including alpha and delta, which have been increasing in California and may have moderately decreased response to some antibody treatments or are more transmissible,” the department told CNN. in a letter.
In Illinois, gamma accounts for more than 25% of the sequence variants, according to Health State Data. According to NowCast data from the US Department of Health and Human Services, gamma prevalence in the US has increased steadily since mid-March.
Gamma: more resistant to vaccines and antibody therapies
Current evidence suggests that gamma can counteract the effects of antibody treatments.
In nine states, HHS discontinued distribution of two monoclonal antibody treatments from Eli Lilly and Co, citing reduced efficacy against both gamma and delta variants.
“Results from laboratory tests used to assess the susceptibility of viral variants to specific monoclonal antibodies indicate that together, bamlanivimab and etesevimab are ineffective against P.1 (Gamma) or B.1.351 (Beta) variants,” HHS said Wednesday.
According to the Centers for Disease Control and Prevention, the gamma variant “significantly reduces susceptibility” to the Lilly treatment, and neutralization reduces post-infection and post-vaccine immunity.
Dr. Peter Hotez says antibody resistance is a major issue in this alternative.
“If you haven’t been vaccinated or if you only receive one dose of the vaccine, you are at risk,” Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, told CNN.
“And now the only effective treatment we have if you give it early is the monoclonal antibody, so if it’s going to run away from the monoclonal antibody, that’s really a problem.”
Hotez said the effect on immunity is linked to mutations — three of them — that change the shape of the virus in the variant, making it difficult for immune system proteins called antibodies to recognize and stick to them.
“Variants that are more resistant to antibodies have the potential to cause some problems in vaccine protection,” John B. Moore, professor of microbiology and immunology at Weill Cornell Medicine, told CNN.
Classifying some of the key variables, Moore said, showing that gamma has greater antibody resistance than alpha, but similar resistance to delta.
“This does not mean that it will eliminate vaccine protection in the United States,” he said.
That’s because authorized vaccines generate much greater protection than that produced by natural infections.
“The two doses, Pfizer and Moderna, should be able to handle this variant very well, because they’re so powerful. J&J may have some issues, but it probably still has enough potency to keep people out of the ICU,” Moore said. “.
However, the spread of variants creates an environment in which the power of vaccination may not last forever.
“The worrying part about all of these variables, is that they keep coming up,” said Ramon Lorenzo Redondo, an infectious disease specialist at Northwestern University Feinberg School of Medicine. And in areas where vaccination is low, variants can spread, multiply and evolve faster, he said.
“In this case, you can push the virus to adapt … not only to transmit faster – they can – but also to evade immunity,” he said.
“Some of these strains have already evolved to evade, at least, natural immunity. However, they are not able to evade the immunity produced by the vaccine,” he said. “If you allow this many cases in non-vaccinated countries or countries that are not fully vaccinated, you are entering a danger zone.”
Anytime the virus infects a person, it multiplies and evolves — and eventually, a variant that is highly resistant to vaccines can emerge.
One in the domain of many variables
This is why the White House is pressing so hard for people to get a full vaccination.
“What we’re observing in a highly vaccinated population, especially in the United States, is that all of these strains are controlled,” Redondo said.
“So even (with) these (variants) that are highly transmissible, if you have good vaccination coverage, it looks like so far, nothing is going to get out of hand.”
Variables can also knock each other out of existence.
Moore told CNN that Delta has shown an ability to “outperform” other variants of Covid-19.
“It cleared up the alpha infection incidents in the UK at the end of last year,” he said – one of many instances where variants have taken over one another.
“We’ve seen this pattern of a transmissible variant dominating a less transmissible variant,” Moore said. “We’ve now seen that four times.”
“We don’t know if gamma has this ability,” he said.
“If delta really does take over, which a lot of people think might happen in the US based on what we’re seeing in the UK in particular, then gamma might get dumped. So the future is hard to predict. So we don’t have information on the relative susceptibility to gamma transmission. “.
Vaccines are still our best tool
Moore said the spread of variants, including but not limited to gamma, should reinforce everyone’s need for full vaccination.
“One dose is not going to be good enough for these resistant variants,” Moore said. “One dose of mRNA is not fully immunized, especially when you encounter these more resistant variants.”
“When you deal with states like Alabama and Arkansas and Mississippi — that part of the country where vaccine uptake is low — people there are very exposed to a more transmissible variant like delta, if released, (or) gamma.”
.
[ad_2]
Picture Credit!